313 related articles for article (PubMed ID: 35805924)
1. Chronic SSRI Treatment, but Not Norepinephrine Reuptake Inhibitor Treatment, Increases Neurogenesis in Juvenile Rats.
Hovorka M; Ewing D; Middlemas DS
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805924
[TBL] [Abstract][Full Text] [Related]
2. Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look?
Chockalingam R; Gott BM; Conway CR
Handb Exp Pharmacol; 2019; 250():37-48. PubMed ID: 30105472
[TBL] [Abstract][Full Text] [Related]
3. Juvenile rats in the forced-swim test model the human response to antidepressant treatment for pediatric depression.
Reed AL; Happe HK; Petty F; Bylund DB
Psychopharmacology (Berl); 2008 Apr; 197(3):433-41. PubMed ID: 18180907
[TBL] [Abstract][Full Text] [Related]
4. The dual-action hypothesis: does pharmacology matter?
Shelton RC
J Clin Psychiatry; 2004; 65 Suppl 17():5-10. PubMed ID: 15600376
[TBL] [Abstract][Full Text] [Related]
5. The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects.
Dell'Osso B; Palazzo MC; Oldani L; Altamura AC
CNS Neurosci Ther; 2011 Dec; 17(6):723-32. PubMed ID: 21155988
[TBL] [Abstract][Full Text] [Related]
6. Antidepressants stimulate hippocampal neurogenesis by inhibiting p21 expression in the subgranular zone of the hipppocampus.
Pechnick RN; Zonis S; Wawrowsky K; Cosgayon R; Farrokhi C; Lacayo L; Chesnokova V
PLoS One; 2011; 6(11):e27290. PubMed ID: 22076148
[TBL] [Abstract][Full Text] [Related]
7. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
[TBL] [Abstract][Full Text] [Related]
8. Other Antidepressants.
Schwasinger-Schmidt TE; Macaluso M
Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
[TBL] [Abstract][Full Text] [Related]
9. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
Thomas SJ; Shin M; McInnis MG; Bostwick JR
Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
[TBL] [Abstract][Full Text] [Related]
11. Depression and adult neurogenesis: Positive effects of the antidepressant fluoxetine and of physical exercise.
Micheli L; Ceccarelli M; D'Andrea G; Tirone F
Brain Res Bull; 2018 Oct; 143():181-193. PubMed ID: 30236533
[TBL] [Abstract][Full Text] [Related]
12. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.
Cryan JF; O'Leary OF; Jin SH; Friedland JC; Ouyang M; Hirsch BR; Page ME; Dalvi A; Thomas SA; Lucki I
Proc Natl Acad Sci U S A; 2004 May; 101(21):8186-91. PubMed ID: 15148402
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of antidepressants: selectivity or multiplicity?
Westenberg HG
J Clin Psychiatry; 1999; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
[TBL] [Abstract][Full Text] [Related]
14. Involvement of organic cation transporter 2 inhibition in potential mechanisms of antidepressant action.
Wang K; Sun S; Li L; Tu M; Jiang H
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():90-8. PubMed ID: 24657329
[TBL] [Abstract][Full Text] [Related]
15. Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD).
Keyloun KR; Hansen RN; Hepp Z; Gillard P; Thase ME; Devine EB
CNS Drugs; 2017 May; 31(5):421-432. PubMed ID: 28378157
[TBL] [Abstract][Full Text] [Related]
16. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus.
Malberg JE; Eisch AJ; Nestler EJ; Duman RS
J Neurosci; 2000 Dec; 20(24):9104-10. PubMed ID: 11124987
[TBL] [Abstract][Full Text] [Related]
17. Bi-phasic change in BDNF gene expression following antidepressant drug treatment.
Coppell AL; Pei Q; Zetterström TS
Neuropharmacology; 2003 Jun; 44(7):903-10. PubMed ID: 12726822
[TBL] [Abstract][Full Text] [Related]
18. Age-dependent decline in hippocampal neurogenesis is not altered by chronic treatment with fluoxetine.
Cowen DS; Takase LF; Fornal CA; Jacobs BL
Brain Res; 2008 Sep; 1228():14-9. PubMed ID: 18616933
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of atypical antipsychotics in depressive syndromes].
Quintin P; Thomas P
Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
[TBL] [Abstract][Full Text] [Related]
20. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study.
Anderson HD; Pace WD; Libby AM; West DR; Valuck RJ
Clin Ther; 2012 Jan; 34(1):113-23. PubMed ID: 22177545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
